Sep 02, 2021

New Insights about Melanocytes Could Lead to More Targeted Melanoma Treatments

Huntsman Cancer Institute melanoma researchers have generated the first “atlas” of where human melanocytes are located in the body. In analyzing the atlas data, the team discovered different types of melanocytes, including what looks to be the cell of origin for an understudied subtype called acral melanoma, which mostly affects people of color.

Jul 19, 2021

Revolutionary Immunotherapy and Ben & Jerry’s: A Melanoma Patient’s Story

Max Rosett faced melanoma as a young adult and a decade later, he is cancer free. He describes how he felt after being diagnosed, the outstanding treatment he received at Huntsman Cancer Institute and the revolutionary immunotherapy clinical trials that helped save his life.

May 11, 2021

New Research Outlines a Critical Driver in an Immune Cell’s Defense against Melanoma

Researchers at Huntsman Cancer Institute have found critical new insights into how cells defend against melanoma. In a report published in Nature Communications, the team describes how an enzyme called nicotinamide phosphoribosyltransferase, or NAMPT, initiates antitumor activity. The researchers suggest that new therapies strengthening this pathway in immune cells could be the foundation for more effective treatments against melanoma.

Apr 08, 2021

Huntsman Cancer Institute Research Shows Melanoma Incidence and Mortality Higher in Utah Compared to Rest of U.S.

Utah had more melanoma deaths than any other state from 1975 to 2013, says a letter published today by HCI researchers in the New England Journal of Medicine. In contrast to the rest of the United States, melanoma mortality in Utah increased by 0.8% per year over that period. The researchers say this data emphasizes the need to stay vigilant about preventing melanoma.

Apr 01, 2021

Banding Together to Advance Scientific Progress

When cancer researchers from different disciplines work together, they gain new insights into how cancer begins and how it can be treated. HCI is committed to providing an atmosphere where ideas can be created, cultivated, and shared. Here are some examples of how HCI scientists are collaborating to accelerate progress in cancer research.

Apr 01, 2021

Finding a Way to Celebrate during a Time with No Visitors

Until the coronavirus pandemic forced hospitals to establish a zero-visitor policy, George Morales accompanied his wife, Rikki, to all her cancer treatments. Though he couldn’t come with her anymore, George was determined to be there when Rikki finished her last chemo treatment. With help from the HCI infusion team, he found a safe way to attend and celebrate with her.

Jan 13, 2021

Talks with Docs: Robert Judson-Torres, Melanoma Researcher

“Any human disease is so complicated that in order to really have the best care for patients, as well as sort of pushing the envelope on research, you need experts in all of it,” says melanoma researcher Robert Judson-Torres, PhD. In this Talks with Docs video, he explains why he wanted to become a cancer researcher, what he hopes his melanoma research will accomplish, and why Indiana Jones is his inspiration.

Dec 03, 2020

Huntsman Cancer Institute Researchers Identify Promising Drug Combination for Melanoma

Researchers at Huntsman Cancer Institute at the University of Utah have identified a potential drug combination to treat uveal melanoma, a type of eye cancer. Lead author Amanda Truong, trainee in the McMahon Lab at HCI, explains uveal melanoma patients frequently have changes in genes called GNAQ and GNA11, which are key targets for these drugs. This study was published in the journal Clinical Cancer Research.